Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

Bootstrap Bio has hired a chief science officer, opened a lab and sought seed funding to edit human cells that can be passed ...

How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and patient access?

Researchers have uncovered how losing the autism-linked gene PTEN in a specific set of inhibitory neurons reshapes brain circuits tied to fear and anxiety.

During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell ...

PepGen leverages a graph-based approach to improve the detection of hidden protein variants in a computationally efficient ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the key takeaways from the ASCO 2025 Annual ...

Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell ...